Evidence mapPaperPMID 41111667Full record

ArticleCureus2025

Computational Pupillometry and the Pupil Reactivity (PuRe) Score in Neurocritical Care: Prospects for High-Accuracy, Lighting-Invariant Neuromonitoring.

Patryk Szczęśniewski, Małgorzata Dudzic, Karol Badowski, Michał Świątek, Martyna Płatnikow, Jakub Klawiter, Wiktor Olszewski, Marta Kowalow, Zuzanna Paryzek, Kacper Pawlak and 6 more

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Patryk SzczęśniewskiDepartment of Neurosurgery, Poznan University of Medical Sciences, Poznan, POL.
Małgorzata DudzicDepartment of Neurosurgery, Joseph Strus Municipal Hospital, Poznan, POL.
Karol BadowskiResearch and Development, Solvemed Inc., Lewes, USA.
Michał ŚwiątekResearch and Development, Solvemed Inc., Lewes, USA.
Martyna PłatnikowDepartment of Neurosurgery, Poznan University of Medical Sciences, Poznan, POL.
Jakub KlawiterDepartment of Neurosurgery, Poznan University of Medical Sciences, Poznan, POL.
Wiktor OlszewskiDepartment of Neurosurgery, Poznan University of Medical Sciences, Poznan, POL.
Marta KowalowDepartment of Neurosurgery, Poznan University of Medical Sciences, Poznan, POL.
Zuzanna ParyzekDepartment of Neurosurgery, Poznan University of Medical Sciences, Poznan, POL.
Kacper PawlakDepartment of Neurosurgery, Poznan University of Medical Sciences, Poznan, POL.
Hugo ChrostResearch and Development, Solvemed Inc., Lewes, USA.
Michal WlodarskiOphthalmology, University College London Institute of Ophthalmology, London, GBR.
Marek DziubińskiResearch and Development, Solvemed Inc., Lewes, USA.
Radosław ChrapkiewiczResearch and Development, Solvemed Inc., Lewes, USA.
Artur DrużdżDepartment of Neurosurgery, Poznan University of Medical Sciences, Poznan, POL.
Bartosz SokółDepartment of Neurosurgery, Poznan University of Medical Sciences, Poznan, POL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction An evaluation of computational pupillometry, implemented through the pupil reactivity (PuRe) pupillometer smartphone-based device, was prospectively carried out in a neuro-ICU cohort to make a lighting-invariant assessment of pupil reactivity and its clinical utility in critical care. Methods This prospective single-center observational pilot study was conducted in the neuro-ICU of a municipal hospital in Poznań, Poland, in 2024. Adult patients admitted with acute neurological conditions such as hemorrhagic stroke, traumatic brain injury, brain tumor, hydrocephalus, or intracranial hypertension were monitored under varying ambient light conditions. Pupillometry measurements were collected using the PuRe pupillometer, a smartphone-based device that computes standard pupillary light reflex parameters and the lighting-invariant Pupil Reactivity (PuRe) Score. Neurological status was assessed via the Glasgow Coma Scale, and survival outcomes were recorded at discharge. Statistical analyses included comparisons across light conditions using non-parametric tests, correlations with clinical variables via Spearman's correlation, and receiver operating characteristic analysis for predictive thresholds. Results Twelve patients, with a median age of 59 years, contributed 1,331 measurements, at 44 measurements per patient, under ambient light ranging from 4 to 1,200 lux. Standard pupillary light reflex parameters showed high light dependence with variations up to 133% (p<0.001), whereas PuRe Scores remained stable with medians of 2.64 in dim light versus 2.42 in bright light (p=0.449; r=-0.026). PuRe Scores correlated strongly with neurological status (Spearman ρ=0.746, p<0.001). At a threshold below 3.0, the PuRe Score identified severe Glasgow Coma Scale scores (≤8) with 84.3% sensitivity, 90.2% specificity, 86% accuracy, and an area under the curve of 0.940. Non-survivors exhibited markedly lower median PuRe Scores of 0.00 compared to 2.82 in survivors (p<0.001), with 91.7% of non-survivor recordings below the 3.0 threshold. Frame-level analysis demonstrated pupil diameter accuracy of ±0.025 mm. Conclusion Lighting-invariant, artificial intelligence (AI)-driven pupillometry provides a precise, clinically meaningful assessment of pupil reactivity, enabling objective bedside neuromonitoring without strict light control and supporting early detection of severe injury and poor outcome.

Indexed as

artificial intelligenceneurocritical careneuromonitoringpupillometrypupil reactivitypupil reactivity (pure)

Identifiers

PMID41111667
PMCPMC12535429

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.